| Company Name: |
Wuxi AppTec |
| Tel: |
022-59987777 13552403979 |
| Email: |
jia_guoqiang@wuxiapptec.com |
|
| | 10-phenyl-3,6,9-trioxadecanoic acid Basic information |
| Product Name: | 10-phenyl-3,6,9-trioxadecanoic acid | | Synonyms: | 10-phenyl-3,6,9-trioxadecanoic acid;2-(2-(2-(benzyloxy)ethoxy)ethoxy)acetic acid;2-(2-(2-(benzyloxy)ethoxy)ethoxy)acetic acid(WXPC0027);BnO-PEG2-CH2COOH;Acetic acid, 2-[2-[2-(phenylmethoxy)ethoxy]ethoxy]-;{2-[2-(Benzyloxy)ethoxy]ethoxy}acetic acid;BnO-PEG2-CH2COOH/Acetic acid, 2-[2-[2-(phenylmethoxy)ethoxy]ethoxy]- | | CAS: | 91842-53-4 | | MF: | C13H18O5 | | MW: | 254.27902 | | EINECS: | | | Product Categories: | | | Mol File: | 91842-53-4.mol |  |
| | 10-phenyl-3,6,9-trioxadecanoic acid Chemical Properties |
| Boiling point | 409.7±30.0 °C(Predicted) | | density | 1.163±0.06 g/cm3(Predicted) | | storage temp. | Storage temp. 2-8°C | | form | Liquid | | pka | 3.39±0.10(Predicted) | | color | Colorless to light yellow |
| | 10-phenyl-3,6,9-trioxadecanoic acid Usage And Synthesis |
| Uses | Benzyl-PEG2-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | | IC 50 | PEGs | | References | [1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005 |
| | 10-phenyl-3,6,9-trioxadecanoic acid Preparation Products And Raw materials |
|